• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将一种新的喹喔啉衍生物包封在 PLGA 中会改变其抗癌效力的模式并诱导细胞凋亡。

Encapsulation of a new quinoxaline derivative in PLGA alters the pattern of its anticancer potency and induces apoptosis.

机构信息

Chemistry Department, Faculty of Science, Damietta University, Damietta, 34517, Egypt.

出版信息

Cancer Chemother Pharmacol. 2019 Apr;83(4):649-658. doi: 10.1007/s00280-019-03770-0. Epub 2019 Jan 16.

DOI:10.1007/s00280-019-03770-0
PMID:30648201
Abstract

PURPOSE

Searching for novel anticancer therapeutics which are effective and primarily less toxic is urgently needed. Drug encapsulation provides more protection of drug within the body with more stable drug circulation levels thus avoiding drug peak-related adverse effects. We aimed first to develop and characterize a nano-particulate drug delivery system using poly(lactic-co-glycolic acid) (PLGA) for the new compound N-butylpyridoquinoxaline 1,4-dioxide (NBPQD), and second to investigate its anticancer effect and the probable mechanism.

METHODS

NBPQD-PLGA nano-particles were prepared and their shape, size, zeta potential, encapsulation efficiency (EE%), drug loading (DL%), drug release, anticancer activity against six human cancer cell lines, DNA binding ability, and flow cytometric analyses of apoptosis, cell cycle and caspase-3 activity were investigated.

RESULTS AND CONCLUSIONS

NBPQD-PLGA nano-particles were spherical with diameter around 54 nm. Zeta potential, EE%, and DL% values were - 20.4 mV, 88% and 21.8%, respectively. Nano-particles exhibited higher marked anticancer activities (much lower ICs) and changed the anticancer potency pattern towards all the studied cell lines compared to free NBPQD with superior potency against colorectal carcinoma (HCT-116, IC of 12.2 µg/mL). NBPQD-PLGA acts by induction of cancer cell apoptosis through oxidative stress, DNA damage, and activating a caspase-3 signaling pathway.

摘要

目的

寻找有效且毒性较低的新型抗癌治疗药物迫在眉睫。药物包封提供了更多的药物保护,使体内药物循环水平更稳定,从而避免与药物峰值相关的不良反应。我们的目的首先是使用聚(乳酸-共-乙醇酸)(PLGA)开发和表征新化合物 N-丁基吡啶并[2,3-d]恶嗪-1,4-二氧化物(NBPQD)的纳米颗粒药物递送系统,其次是研究其抗癌作用和可能的机制。

方法

制备 NBPQD-PLGA 纳米颗粒,并对其形状、大小、Zeta 电位、包封效率(EE%)、载药量(DL%)、药物释放、对六种人癌细胞系的抗癌活性、DNA 结合能力以及流式细胞术分析细胞凋亡、细胞周期和 caspase-3 活性进行研究。

结果与结论

NBPQD-PLGA 纳米颗粒呈球形,直径约为 54nm。Zeta 电位、EE%和 DL%值分别为-20.4mV、88%和 21.8%。纳米颗粒表现出更高的抗癌活性(更低的 IC 值),并改变了所有研究细胞系的抗癌效力模式,与游离 NBPQD 相比,对结直肠癌细胞(HCT-116,IC 为 12.2μg/mL)具有更强的效力。NBPQD-PLGA 通过诱导癌细胞凋亡、氧化应激、DNA 损伤和激活 caspase-3 信号通路来发挥作用。

相似文献

1
Encapsulation of a new quinoxaline derivative in PLGA alters the pattern of its anticancer potency and induces apoptosis.将一种新的喹喔啉衍生物包封在 PLGA 中会改变其抗癌效力的模式并诱导细胞凋亡。
Cancer Chemother Pharmacol. 2019 Apr;83(4):649-658. doi: 10.1007/s00280-019-03770-0. Epub 2019 Jan 16.
2
Loading of some quinoxaline derivatives in poly (l-lactic) acid/Pluronic® F-127 nanofibers enhances their anticancer efficiency and induces a p53 and p21 apoptotic-signaling pathway.聚(L-乳酸)/普朗尼克® F-127纳米纤维中某些喹喔啉衍生物的负载增强了它们的抗癌效率,并诱导p53和p21凋亡信号通路。
Colloids Surf B Biointerfaces. 2019 Nov 1;183:110444. doi: 10.1016/j.colsurfb.2019.110444. Epub 2019 Aug 17.
3
Synthesis of novel coumarin-triazole hybrids and first evaluation of the 4-phenyl substituted hybrid loaded PLGA nanoparticles delivery system to the anticancer activity.新型香豆素-三唑杂合体的合成及载有 4-苯基取代杂合体的 PLGA 纳米粒子递药系统的抗癌活性的初步评价。
Nanotechnology. 2024 May 7;35(30). doi: 10.1088/1361-6528/ad403e.
4
The Potential of Atractylodin-Loaded PLGA Nanoparticles as Chemotherapeutic for Cholangiocarcinoma.阿魏酸载质体胶束纳米粒作为胆管癌化疗药物的潜力。
Asian Pac J Cancer Prev. 2020 Apr 1;21(4):935-941. doi: 10.31557/APJCP.2020.21.4.935.
5
A novel nanoformulation of parthenolide coated with polydopamine shows selective cytotoxicity and induces apoptosis in gastric cancer cells.一种用聚多巴胺包覆的小白菊内酯新型纳米制剂显示出对胃癌细胞的选择性细胞毒性并诱导其凋亡。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Jun;397(6):4435-4445. doi: 10.1007/s00210-023-02907-6. Epub 2023 Dec 18.
6
Chitooligosaccharides-modified PLGA nanoparticles enhance the antitumor efficacy of AZD9291 (Osimertinib) by promoting apoptosis.壳寡糖修饰的 PLGA 纳米粒通过促进细胞凋亡增强 AZD9291(奥希替尼)的抗肿瘤疗效。
Int J Biol Macromol. 2020 Nov 1;162:262-272. doi: 10.1016/j.ijbiomac.2020.06.154. Epub 2020 Jun 20.
7
Poly-(Lactic-co-Glycolic) Acid Nanoparticles for Synergistic Delivery of Epirubicin and Paclitaxel to Human Lung Cancer Cells.聚(丙交酯-共-乙交酯)酸纳米粒协同递送表阿霉素和紫杉醇至人肺癌细胞。
Molecules. 2020 Sep 16;25(18):4243. doi: 10.3390/molecules25184243.
8
Nano-Co-Delivery of Berberine and Anticancer Drug Using PLGA Nanoparticles: Exploration of Better Anticancer Activity and In Vivo Kinetics.载姜黄素和抗癌药物的 PLGA 纳米粒的纳米共递送:抗癌活性和体内动力学的探索。
Pharm Res. 2019 Aug 16;36(10):149. doi: 10.1007/s11095-019-2677-5.
9
Synthesis, purification, and anticancer effect of magnetic FeO-loaded poly (lactic-co-glycolic) nanoparticles of the natural drug tetrandrine.磁性负载四氢巴马汀的聚乳酸-共-羟基乙酸纳米粒子的合成、纯化及抗癌作用。
J Microencapsul. 2019 Jun;36(4):356-370. doi: 10.1080/02652048.2019.1631403. Epub 2019 Jun 27.
10
Synergistic induction of apoptosis in lung cancer cells through co-delivery of PLGA phytol/α-bisabolol nanoparticles.通过共递送 PLGA 植醇/α- 没药醇纳米粒协同诱导肺癌细胞凋亡。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Jul;397(7):5131-5144. doi: 10.1007/s00210-023-02935-2. Epub 2024 Jan 19.

引用本文的文献

1
Synergistic impacts of rifampicin and doxorubicin against thioacetamide-induced hepatocellular carcinoma in rats.利福平与阿霉素对硫代乙酰胺诱导的大鼠肝细胞癌的协同作用
Liver Res. 2023 Nov 25;7(4):352-360. doi: 10.1016/j.livres.2023.11.005. eCollection 2023 Dec.
2
Biochemical and pathophysiological improvements in rats with thioacetamide induced-hepatocellular carcinoma using aspirin plus vitamin C.阿司匹林加维生素 C 对硫代乙酰胺诱导的大鼠肝癌的生化和病理生理学改善。
BMC Cancer. 2023 Feb 21;23(1):175. doi: 10.1186/s12885-023-10644-5.
3
A Newly Synthesized Derivative and a Natural Parent Molecule: Which Would Be More Beneficial as a Future Antitumor Candidate? Docking and In Vivo Study.
一种新合成的衍生物和天然母体分子:作为未来的抗肿瘤候选药物,哪一个更有优势?对接和体内研究。
Appl Biochem Biotechnol. 2022 Nov;194(11):5386-5402. doi: 10.1007/s12010-022-04037-w. Epub 2022 Jul 2.